Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000307977 is a long non-coding RNA gene registered as a novel transcript antisense to FAM19A1 (also known as TAFA1). It does not encode a protein but may overlap the FAM19A1 gene on the opposite DNA strand. There are currently no detailed data about its function, disease association, or pharmacological relevance. FAM19A1 (TAFA1) is a protein-coding gene, unrelated to the transcript in question except for genomic overlap. The antisense transcript conforms to long non-coding RNA naming conventions, but its function, if any, has not been characterized in the literature or gene databases.
Not applicable (no known targeted drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to FAM19A1.